DUREZOL is a Ophthalmic Emulsion in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Difluprednate.
| Product ID | 0065-9240_4233aadc-4527-4431-94be-1b5604a9938e |
| NDC | 0065-9240 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DUREZOL |
| Generic Name | Durezol |
| Dosage Form | Emulsion |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2011-01-25 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022212 |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | DIFLUPREDNATE |
| Active Ingredient Strength | 1 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2013-05-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022212 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-05-15 |
| Marketing Category | NDA |
| Application Number | NDA022212 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2013-05-15 |
| Marketing Category | NDA |
| Application Number | NDA022212 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2011-01-25 |
| Marketing End Date | 2015-02-28 |
| Ingredient | Strength |
|---|---|
| DIFLUPREDNATE | .5 mg/mL |
| SPL SET ID: | d07b65d5-f8e3-4594-a7fb-108218746cec |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0065-9240 | DUREZOL | DUREZOL |
| 0078-0862 | DUREZOL | difluprednate |
| 0781-6000 | DUREZOL | Difluprednate Ophthalmic Emulsion |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DUREZOL 77830018 3784208 Live/Registered |
NOVARTIS AG 2009-09-18 |
![]() DUREZOL 77340065 not registered Dead/Abandoned |
Sirion Therapeutics, Inc. 2007-11-29 |